{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:42:18Z","timestamp":1772142138293,"version":"3.50.1"},"reference-count":175,"publisher":"Elsevier","isbn-type":[{"value":"9780128014806","type":"print"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/bs.irn.2015.05.002","type":"book-chapter","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T15:49:19Z","timestamp":1434728959000},"page":"25-58","source":"Crossref","is-referenced-by-count":15,"title":["The Potential of Proteomics in Understanding Neurodegeneration"],"prefix":"10.1016","author":[{"given":"Ramavati","family":"Pal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Petter","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Geir","family":"Moller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.irn.2015.05.002_bb0005","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/pr400942n","article-title":"Human SOD1-G93A specific distribution evidenced in murine brain of a transgenic model for amyotrophic lateral sclerosis by MALDI imaging mass spectrometry","volume":"13","author":"Acquadro","year":"2014","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bfgp\/ell018","article-title":"Shotgun proteomics using the iTRAQ isobaric tags","volume":"5","author":"Aggarwal","year":"2006","journal-title":"Briefings in Functional Genomics & Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10715769709065765","article-title":"Oxidative modification of glutamine synthetase by amyloid beta peptide","volume":"27","author":"Aksenov","year":"1997","journal-title":"Free Radical Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0020","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1742-4658.2010.07896.x","article-title":"Proteomic analysis of dopamine and alpha-synuclein interplay in a cellular model of Parkinson's disease pathogenesis","volume":"277","author":"Alberio","year":"2010","journal-title":"The FEBS Journal"},{"key":"10.1016\/bs.irn.2015.05.002_bb0025","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/iub.1073","article-title":"Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease","volume":"64","author":"Alberio","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/bs.irn.2015.05.002_bb0030","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1002\/elps.201200307","article-title":"Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia","volume":"33","author":"Albertini","year":"2012","journal-title":"Electrophoresis"},{"key":"10.1016\/bs.irn.2015.05.002_bb0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1373\/clinchem.2006.082644","article-title":"Reproducibility in protein profiling by MALDI-TOF mass spectrometry","volume":"53","author":"Albrethsen","year":"2007","journal-title":"Clinical Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0040","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1021\/jf304729f","article-title":"Rapid method for the determination of multiple mycotoxins in wines and beers by LC-MS\/MS using a stable isotope dilution assay","volume":"61","author":"Al-Taher","year":"2013","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0045","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/elps.1150191103","article-title":"Proteome and proteomics: New technologies, new concepts, and new words","volume":"19","author":"Anderson","year":"1998","journal-title":"Electrophoresis"},{"key":"10.1016\/bs.irn.2015.05.002_bb0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00216-012-6203-4","article-title":"Quantitative mass spectrometry in proteomics: Critical review update from 2007 to the present","volume":"404","author":"Bantscheff","year":"2012","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0055","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00415-005-0742-y","article-title":"SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study","volume":"252","author":"Battistini","year":"2005","journal-title":"Journal of Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0060","doi-asserted-by":"crossref","first-page":"30359","DOI":"10.1074\/jbc.M203201200","article-title":"Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells","volume":"277","author":"Bazan","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0065","first-page":"40","article-title":"Hereditary ataxias and paraplegias: A clinicogenetic review","volume":"17","author":"Berciano","year":"2002","journal-title":"Neurolog\u00eda"},{"key":"10.1016\/bs.irn.2015.05.002_bb0070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nmeth1007-785","article-title":"Proteomics from the clinical perspective: Many hopes and much debate","volume":"4","author":"Beretta","year":"2007","journal-title":"Nature Methods"},{"key":"10.1016\/bs.irn.2015.05.002_bb0075","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1074\/mcp.M900046-MCP200","article-title":"Changes in the spinal cord proteome of an amyotrophic lateral sclerosis murine model determined by differential in-gel electrophoresis","volume":"8","author":"Bergemalm","year":"2009","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(09)70363-1","article-title":"Shaking the genome: New studies reveal genetic risk for Parkinson's disease","volume":"9","author":"Bonifati","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0085","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00018-004-4104-1","article-title":"Unraveling the pathogenesis of Parkinson's disease\u2014The contribution of monogenic forms","volume":"61","author":"Bonifati","year":"2004","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"7","key":"10.1016\/bs.irn.2015.05.002_bb0090","first-page":"1","article-title":"HPLC of peptides and proteins","volume":"8","author":"Boysen","year":"2001","journal-title":"Current Protocols in Protein Science"},{"key":"10.1016\/bs.irn.2015.05.002_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neulet.2009.10.053","article-title":"Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS)","volume":"468","author":"Brettschneider","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2015.05.002_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pharmthera.2007.02.002","article-title":"Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease","volume":"114","author":"Burke","year":"2007","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2003.12.012","article-title":"Proteomics: A new approach to investigate oxidative stress in Alzheimer's disease brain","volume":"1000","author":"Butterfield","year":"2004","journal-title":"Brain Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0110","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1089\/ars.2012.4742","article-title":"Redox proteomics","volume":"17","author":"Butterfield","year":"2012","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/bs.irn.2015.05.002_bb0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/1568026613666131204120747","article-title":"Using mass spectrometry-based peptidomics to understand the brain and disorders such as Parkinson's disease and schizophrenia","volume":"14","author":"Cafe-Mendes","year":"2014","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0120","doi-asserted-by":"crossref","first-page":"e74439","DOI":"10.1371\/journal.pone.0074439","article-title":"Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeys","volume":"8","author":"Campello","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2015.05.002_bb0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pmic.201300130","article-title":"Proteome characterization of splenocytes from an Abetapp\/ps-1 Alzheimer's disease model","volume":"14","author":"Cao","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0130","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cellsig.2010.01.006","article-title":"Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway","volume":"22","author":"Carballo-Carbajal","year":"2010","journal-title":"Cellular Signalling"},{"key":"10.1016\/bs.irn.2015.05.002_bb0135","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bbrc.2012.11.093","article-title":"Proteomic profiling of brain cortex tissues in a Tau transgenic mouse model of Alzheimer's disease","volume":"430","author":"Chang","year":"2013","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.irn.2015.05.002_bb0140","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1074\/mcp.M600356-MCP200","article-title":"Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach","volume":"6","author":"Chiang","year":"2007","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jprot.2010.12.012","article-title":"Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease","volume":"74","author":"Chou","year":"2011","journal-title":"Journal of Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0150","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.freeradbiomed.2012.08.596","article-title":"Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics","volume":"53","author":"Cocciolo","year":"2012","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/bs.irn.2015.05.002_bb0155","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.parkreldis.2010.06.011","article-title":"Proteomic profiling of cerebrospinal fluid in parkinsonian disorders","volume":"16","author":"Constantinescu","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2015.05.002_bb0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10540-006-9028-6","article-title":"Genes and the environment in neurodegeneration","volume":"26","author":"Coppede","year":"2006","journal-title":"Bioscience Reports"},{"key":"10.1016\/bs.irn.2015.05.002_bb0165","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nmeth1094","article-title":"MALDI imaging mass spectrometry: Molecular snapshots of biochemical systems","volume":"4","author":"Cornett","year":"2007","journal-title":"Nature Methods"},{"key":"10.1016\/bs.irn.2015.05.002_bb0170","doi-asserted-by":"crossref","first-page":"21599","DOI":"10.1074\/jbc.M112.359307","article-title":"Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis","volume":"287","author":"Culver","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0175","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.2174\/138161209789649330","article-title":"Kinase inhibitors as potential therapeutics for acute and chronic neurodegenerative conditions","volume":"15","author":"Cuny","year":"2009","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/bs.irn.2015.05.002_bb0180","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1074\/mcp.M500226-MCP200","article-title":"Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease","volume":"5","author":"D'Ambrosio","year":"2006","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0190","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"David","year":"2006","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2015.05.002_bb0195","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brainresbull.2011.01.012","article-title":"Proteomic changes in the brains of Huntington's disease mouse models reflect pathology and implicate mitochondrial changes","volume":"88","author":"Deschepper","year":"2012","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.irn.2015.05.002_bb0200","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jprot.2011.03.033","article-title":"Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects","volume":"74","author":"Di Domenico","year":"2011","journal-title":"Journal of Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0205","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/hmg\/ddr026","article-title":"Cyclin-G-associated kinase modifies alpha-synuclein expression levels and toxicity in Parkinson's disease: Results from the GenePD study","volume":"20","author":"Dumitriu","year":"2011","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0210","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/1044-0305(94)80016-2","article-title":"An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database","volume":"5","author":"Eng","year":"1994","journal-title":"Journal of the American Society for Mass Spectrometry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0215","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.1997.69030889.x","article-title":"Phospholipase A2 and its role in brain tissue","volume":"69","author":"Farooqui","year":"1997","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14789450.5.2.239","article-title":"Alpha-synuclein and Parkinson's disease: A proteomic view","volume":"5","author":"Fasano","year":"2008","journal-title":"Expert Review of Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0225","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/ac0258709","article-title":"A method for assessing the statistical significance of mass spectrometry-based protein identifications using general scoring schemes","volume":"75","author":"Fenyo","year":"2003","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0230","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cfg.82","article-title":"Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks","volume":"2","author":"Fiehn","year":"2001","journal-title":"Comparative and Functional Genomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0235","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/elps.200500738","article-title":"Proteomics-driven progress in neurodegeneration research","volume":"27","author":"Fountoulakis","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/bs.irn.2015.05.002_bb0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000334285","article-title":"Update on genetics of parkinsonism","volume":"10","author":"Fujioka","year":"2012","journal-title":"Neuro-Degenerative Diseases"},{"key":"10.1016\/bs.irn.2015.05.002_bb0245","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nature Cell Biology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0250","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","article-title":"A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1","volume":"51","author":"Funayama","year":"2002","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0255","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.wco.0000170951.08924.3d","article-title":"Genetics of Parkinson's disease","volume":"18","author":"Gasser","year":"2005","journal-title":"Current Opinion in Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0260","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/pmic.200300435","article-title":"Redox proteomics: Identification of oxidatively modified proteins","volume":"3","author":"Ghezzi","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0265","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1016\/bs.irn.2015.05.002_bb0270","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1021\/pr9008578","article-title":"Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2","volume":"9","author":"Gloeckner","year":"2010","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0275","first-page":"165","article-title":"Alpha-synuclein and Parkinson's disease","volume":"91","author":"Golbe","year":"2003","journal-title":"Advances in Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0280","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1002\/pmic.200401031","article-title":"Current two-dimensional electrophoresis technology for proteomics","volume":"4","author":"Gorg","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0285","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10540-005-2849-x","article-title":"Application of mass spectrometry in proteomics","volume":"25","author":"Guerrera","year":"2005","journal-title":"Bioscience Reports"},{"key":"10.1016\/bs.irn.2015.05.002_bb0290","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/13690","article-title":"Quantitative analysis of complex protein mixtures using isotope-coded affinity tags","volume":"17","author":"Gygi","year":"1999","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0295","first-page":"635","article-title":"2-D or not 2-D\u2014Is there a future for 2-D gels in proteomics? Insights from the York proteomics meeting","volume":"5","author":"Hanash","year":"2001","journal-title":"Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0300","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature01514","article-title":"Disease proteomics","volume":"422","author":"Hanash","year":"2003","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2015.05.002_bb0305","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00401-010-0703-0","article-title":"Neurotoxic protein oligomerisation associated with polyglutamine diseases","volume":"120","author":"Hands","year":"2010","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/bs.irn.2015.05.002_bb0310","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-1-59745-188-8_17","article-title":"Quantitative protein profiling by mass spectrometry using label-free proteomics","volume":"439","author":"Haqqani","year":"2008","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0315","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.21022","article-title":"Genetics of Parkinson's disease and parkinsonism","volume":"60","author":"Hardy","year":"2006","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0320","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/bs.irn.2015.05.002_bb0325","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00702-012-0781-3","article-title":"Multidimensional plasma protein separation technique for identification of potential Alzheimer's disease plasma biomarkers: A pilot study","volume":"119","author":"Henkel","year":"2012","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/bs.irn.2015.05.002_bb0330","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1046\/j.1471-4159.1995.65052146.x","article-title":"Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation","volume":"65","author":"Hensley","year":"1995","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0335","first-page":"3","article-title":"Electrospray ionisation mass spectrometry: Principles and clinical applications","volume":"24","author":"Ho","year":"2003","journal-title":"Clinical Biochemist Reviews"},{"key":"10.1016\/bs.irn.2015.05.002_bb0340","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1192\/bjp.180.2.131","article-title":"Genotype and phenotype in Alzheimer's disease","volume":"180","author":"Holmes","year":"2002","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0345","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-130311","article-title":"Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology","volume":"36","author":"Hong","year":"2013","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/bs.irn.2015.05.002_bb0350","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000285509","article-title":"LRRK2 and the stress response: Interaction with MKKs and JNK-interacting proteins","volume":"7","author":"Hsu","year":"2010","journal-title":"Neuro-Degenerative Diseases"},{"key":"10.1016\/bs.irn.2015.05.002_bb0355","doi-asserted-by":"crossref","first-page":"e15809","DOI":"10.1371\/journal.pone.0015809","article-title":"Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2015.05.002_bb0360","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/mds.24994","article-title":"Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy","volume":"27","author":"Ishigami","year":"2012","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2015.05.002_bb0365","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/bbrc.2002.6678","article-title":"The SELDI-TOF MS approach to proteomics: Protein profiling and biomarker identification","volume":"292","author":"Issaq","year":"2002","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.irn.2015.05.002_bb0370","doi-asserted-by":"crossref","first-page":"e26540","DOI":"10.1371\/journal.pone.0026540","article-title":"Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: Identification and prospective evaluation of new synaptic biomarkers","volume":"6","author":"Jahn","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2015.05.002_bb0375","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/1522-2683(20000701)21:13<2641::AID-ELPS2641>3.0.CO;2-5","article-title":"A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics","volume":"21","author":"Joos","year":"2000","journal-title":"Electrophoresis"},{"key":"10.1016\/bs.irn.2015.05.002_bb0380","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1523\/JNEUROSCI.18-18-07402.1998","article-title":"A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein","volume":"18","author":"Kawamata","year":"1998","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2015.05.002_bb0385","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/prca.201200087","article-title":"Apolipoprotein A-I: Insights from redox proteomics for its role in neurodegeneration","volume":"7","author":"Keeney","year":"2013","journal-title":"Proteomics. Clinical Applications"},{"key":"10.1016\/bs.irn.2015.05.002_bb0390","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.molcel.2011.08.025","article-title":"Systematic and quantitative assessment of the ubiquitin-modified proteome","volume":"44","author":"Kim","year":"2011","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.irn.2015.05.002_bb0395","first-page":"285","article-title":"Going global: Protein expression profiling using shotgun mass spectrometry","volume":"5","author":"Kislinger","year":"2003","journal-title":"Current Opinion in Molecular Therapeutics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0400","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2900","article-title":"Functional proteomics to dissect tyrosine kinase signalling pathways in cancer","volume":"10","author":"Kolch","year":"2010","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.irn.2015.05.002_bb0405","doi-asserted-by":"crossref","first-page":"11969","DOI":"10.1073\/pnas.172183199","article-title":"Proteomic survey of metabolic pathways in rice","volume":"99","author":"Koller","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2015.05.002_bb0410","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1111\/j.1742-4658.2009.07344.x","article-title":"LRRK2 in Parkinson's disease: Genetic and clinical studies from patients","volume":"276","author":"Kumari","year":"2009","journal-title":"The FEBS Journal"},{"key":"10.1016\/bs.irn.2015.05.002_bb0415","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","article-title":"The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: The role of Abeta1-42","volume":"78","author":"Lauderback","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0420","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.expneurol.2012.01.024","article-title":"iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia","volume":"234","author":"Lehnert","year":"2012","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0425","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1101\/gr.2523904","article-title":"Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle","volume":"14","author":"Le Roch","year":"2004","journal-title":"Genome Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0430","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1021\/pr100389u","article-title":"Differential proteome of the striatum from hemiparkinsonian rats displays vivid structural remodeling processes","volume":"9","author":"Lessner","year":"2010","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0435","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1750-3639.2007.00048.x","article-title":"Proteomic identification of novel proteins in cortical Lewy bodies","volume":"17","author":"Leverenz","year":"2007","journal-title":"Brain Pathology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0440","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000323427","article-title":"Matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in Parkinson's disease","volume":"65","author":"Li","year":"2011","journal-title":"European Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0445","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1745-7270.2008.00416.x","article-title":"Chaperone proteins identified from synthetic proteasome inhibitor-induced inclusions in PC12 cells by proteomic analysis","volume":"40","author":"Li","year":"2008","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"10.1016\/bs.irn.2015.05.002_bb0450","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.jprot.2012.02.032","article-title":"Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease","volume":"75","author":"Licker","year":"2012","journal-title":"Journal of Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0455","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/pmic.200900651","article-title":"Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction","volume":"10","author":"Lim","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0460","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2015.05.002_bb0465","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/srep00954","article-title":"DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease","volume":"2","author":"Lin","year":"2012","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.irn.2015.05.002_bb0470","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/hh0402.105757","article-title":"Applied proteomics: Mitochondrial proteins and effect on function","volume":"90","author":"Lopez","year":"2002","journal-title":"Circulation Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0475","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.arcmed.2010.03.007","article-title":"The revitalized tau hypothesis on Alzheimer's disease","volume":"41","author":"Maccioni","year":"2010","journal-title":"Archives of Medical Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0480","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1016\/bs.irn.2015.05.002_bb0485","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jnnp-2012-303455","article-title":"Parkinson's disease subtypes: Lost in translation?","volume":"84","author":"Marras","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0490","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1471-4159.2011.07576.x","article-title":"alpha-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases","volume":"120","author":"Martin","year":"2012","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0495","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1152\/physiolgenomics.00282.2007","article-title":"Biomarker discovery: Proteome fractionation and separation in biological samples","volume":"33","author":"Matt","year":"2008","journal-title":"Physiological Genomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0500","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1383-5742(02)00046-7","article-title":"Genetic and environmental factors in cancer and neurodegenerative diseases","volume":"512","author":"Migliore","year":"2002","journal-title":"Mutation Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0505","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0076-6879(06)12005-4","article-title":"Proteomics of polyglutamine aggregates","volume":"412","author":"Mitsui","year":"2006","journal-title":"Methods in Enzymology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0510","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","article-title":"Alzheimer's disease\u2014Do tauists and baptists finally shake hands?","volume":"25","author":"Mudher","year":"2002","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/bs.irn.2015.05.002_bb0515","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1074\/mcp.M800454-MCP200","article-title":"Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease","volume":"8","author":"Nilsson","year":"2009","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0520","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1074\/mcp.M200025-MCP200","article-title":"Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics","volume":"1","author":"Ong","year":"2002","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0525","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1021\/pr700630x","article-title":"Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption\/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF\/TOF) platform","volume":"7","author":"Pan","year":"2008","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0530","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/GIM.0b013e31815bf97c","article-title":"Genetics of Parkinson disease","volume":"9","author":"Pankratz","year":"2007","journal-title":"Genetics in Medicine"},{"key":"10.1016\/bs.irn.2015.05.002_bb0535","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mrfmmm.2005.06.006","article-title":"In search of genes involved in neurodegenerative disorders","volume":"592","author":"Pardo","year":"2005","journal-title":"Mutation Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0540","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/01.wnl.0000203129.82104.07","article-title":"Identification of potential CSF biomarkers in ALS","volume":"66","author":"Pasinetti","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0545","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nbt849","article-title":"A proteomics approach to understanding protein ubiquitination","volume":"21","author":"Peng","year":"2003","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0550","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1471-4159.2005.03442.x","article-title":"Proteomic analysis of parkin knockout mice: Alterations in energy metabolism, protein handling and synaptic function","volume":"95","author":"Periquet","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0555","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.arr.2013.12.005","article-title":"Redox proteomics and the dynamic molecular landscape of the aging brain","volume":"13","author":"Perluigi","year":"2014","journal-title":"Ageing Research Reviews"},{"key":"10.1016\/bs.irn.2015.05.002_bb0560","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jprot.2013.07.015","article-title":"Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis","volume":"94","author":"Plum","year":"2013","journal-title":"Journal of Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0565","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1471-4159.2005.03478.x","article-title":"Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis","volume":"95","author":"Ranganathan","year":"2005","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0570","first-page":"195","article-title":"Replication of GWAS associations for GAK and MAPT in Parkinson's disease","volume":"75","author":"Rhodes","year":"2011","journal-title":"Annals of Human Genetics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0575","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainresbull.2009.04.018","article-title":"Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease","volume":"80","author":"Riederer","year":"2009","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.irn.2015.05.002_bb0580","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/jxb\/ern252","article-title":"Redox proteomics: Basic principles and future perspectives for the detection of protein oxidation in plants","volume":"59","author":"Rinalducci","year":"2008","journal-title":"Journal of Experimental Botany"},{"key":"10.1016\/bs.irn.2015.05.002_bb0585","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archneurol.2011.642","article-title":"Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations","volume":"69","author":"Ringman","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0590","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/epr.10.43","article-title":"Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases","volume":"7","author":"Rodolfo","year":"2010","journal-title":"Expert Review of Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0595","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1074\/mcp.M400129-MCP200","article-title":"Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents","volume":"3","author":"Ross","year":"2004","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0600","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1096\/fj.10-157859","article-title":"Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M\/H) in Alzheimer's disease by iTRAQ","volume":"24","author":"Rudrabhatla","year":"2010","journal-title":"FASEB Journal"},{"key":"10.1016\/bs.irn.2015.05.002_bb0605","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jnnp.69.5.664","article-title":"Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease","volume":"69","author":"Saez-Valero","year":"2000","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0610","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.3390\/ijms131113926","article-title":"The proteomics big challenge for biomarkers and new drug-targets discovery","volume":"13","author":"Savino","year":"2012","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2015.05.002_bb0615","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1088176","article-title":"Nuclear membrane proteins with potential disease links found by subtractive proteomics","volume":"301","author":"Schirmer","year":"2003","journal-title":"Science"},{"key":"10.1016\/bs.irn.2015.05.002_bb0620","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/1615-9861(200111)1:12<1519::AID-PROT1519>3.0.CO;2-L","article-title":"Proteomic analysis of the brain in Alzheimer's disease: Molecular phenotype of a complex disease process","volume":"1","author":"Schonberger","year":"2001","journal-title":"Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0625","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","article-title":"Targeting the mitogen-activated protein kinase cascade to treat cancer","volume":"4","author":"Sebolt-Leopold","year":"2004","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.irn.2015.05.002_bb0630","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3233\/JAD-2004-6306","article-title":"Proteome analysis of brain proteins in Alzheimer's disease: Subproteomics following sequentially extracted protein preparation","volume":"6","author":"Shiozaki","year":"2004","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/bs.irn.2015.05.002_bb0635","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","article-title":"Network organization of the huntingtin proteomic interactome in mammalian brain","volume":"75","author":"Shirasaki","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2015.05.002_bb0640","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0968-0896(98)00089-3","article-title":"Eponemycin analogues: Syntheses and use as probes of angiogenesis","volume":"6","author":"Sin","year":"1998","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0645","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2008.09.026","article-title":"Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: A proteomic approach","volume":"400","author":"Sinha","year":"2009","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/bs.irn.2015.05.002_bb0650","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10863-009-9254-2","article-title":"Mitochondrial dysfunction in mouse models of Parkinson's disease revealed by transcriptomics and proteomics","volume":"41","author":"Smith","year":"2009","journal-title":"Journal of Bioenergetics and Biomembranes"},{"key":"10.1016\/bs.irn.2015.05.002_bb0655","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/elps.200500026","article-title":"Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining","volume":"26","author":"Stasyk","year":"2005","journal-title":"Electrophoresis"},{"key":"10.1016\/bs.irn.2015.05.002_bb0660","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3892\/ijmm.2012.1056","article-title":"Mass spectrometry-based proteomic analysis of middle-aged vs. aged vastus lateralis reveals increased levels of carbonic anhydrase isoform 3 in senescent human skeletal muscle","volume":"30","author":"Staunton","year":"2012","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/bs.irn.2015.05.002_bb0665","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/pmic.200300434","article-title":"Global quantitative phosphoprotein analysis using multiplexed proteomics technology","volume":"3","author":"Steinberg","year":"2003","journal-title":"Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0670","doi-asserted-by":"crossref","first-page":"65","DOI":"10.15690\/vramn.v68i1.540","article-title":"Proteomics as a fundamental tool for subclinical screening, tests verification and assessment of applied therapy","volume":"1","author":"Suchkov","year":"2013","journal-title":"Vestnik Rossi\u012dsko\u012d Akademii Meditsinskikh Nauk"},{"key":"10.1016\/bs.irn.2015.05.002_bb0675","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-131823","article-title":"Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: Implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease","volume":"40","author":"Sui","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/bs.irn.2015.05.002_bb0680","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3233\/JAD-132033","article-title":"Hyperhomocysteinemia and bleomycin hydrolase modulate the expression of mouse brain proteins involved in neurodegeneration","volume":"40","author":"Suszynska-Zajczyk","year":"2014","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/bs.irn.2015.05.002_bb0685","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1742-2094-9-199","article-title":"Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-beta production in human neuron-like cells","volume":"9","author":"Sutinen","year":"2012","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.irn.2015.05.002_bb0690","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2012.11.010","article-title":"Proteomic analysis of the hippocampus in Alzheimer's disease model mice by using two-dimensional fluorescence difference in gel electrophoresis","volume":"534","author":"Takano","year":"2013","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2015.05.002_bb0695","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ana.410180302","article-title":"Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management","volume":"18","author":"Tandan","year":"1985","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0700","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.410180402","article-title":"Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis","volume":"18","author":"Tandan","year":"1985","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0705","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1126\/science.1067122","article-title":"Toxic proteins in neurodegenerative disease","volume":"296","author":"Taylor","year":"2002","journal-title":"Science"},{"key":"10.1016\/bs.irn.2015.05.002_bb0710","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/ac0262560","article-title":"Tandem mass tags: A novel quantification strategy for comparative analysis of complex protein mixtures by MS\/MS","volume":"75","author":"Thompson","year":"2003","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0715","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0025-7125(02)00003-2","article-title":"Genetics of dementia","volume":"86","author":"Tsuang","year":"2002","journal-title":"The Medical Clinics of North America"},{"key":"10.1016\/bs.irn.2015.05.002_bb0720","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd2092","article-title":"Targeting proteases: Successes, failures and future prospects","volume":"5","author":"Turk","year":"2006","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.irn.2015.05.002_bb0725","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nature01510","article-title":"From genomics to proteomics","volume":"422","author":"Tyers","year":"2003","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2015.05.002_bb0730","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/elps.1150181133","article-title":"Difference gel electrophoresis. A single gel method for detecting changes in protein extracts","volume":"18","author":"\u00dcnl\u00fc","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/bs.irn.2015.05.002_bb0735","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/bs.irn.2015.05.002_bb0740","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/319522","article-title":"Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36","volume":"68","author":"Valente","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0745","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s00216-012-5757-5","article-title":"Stable isotope dilution assay for the accurate determination of mycotoxins in maize by UHPLC-MS\/MS","volume":"402","author":"Varga","year":"2012","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0750","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","article-title":"Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease","volume":"3","author":"Vijitruth","year":"2006","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/bs.irn.2015.05.002_bb0755","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/nprot.2008.150","article-title":"The SCX\/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry","volume":"3","author":"Villen","year":"2008","journal-title":"Nature Protocols"},{"key":"10.1016\/bs.irn.2015.05.002_bb0760","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1021\/pr400758d","article-title":"Quantitative proteomics reveals oxygen-dependent changes in neuronal mitochondria affecting function and sensitivity to rotenone","volume":"12","author":"Villeneuve","year":"2013","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0765","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/85686","article-title":"Large-scale analysis of the yeast proteome by multidimensional protein identification technology","volume":"19","author":"Washburn","year":"2001","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0770","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1074\/jbc.M112.418871","article-title":"Monomeric synucleins generate membrane curvature","volume":"288","author":"Westphal","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0775","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1016\/bs.irn.2015.05.002_bb0780","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ymeth.2012.03.018","article-title":"A novel peptidomics approach to detect markers of Alzheimer's disease in cerebrospinal fluid","volume":"56","author":"Wijte","year":"2012","journal-title":"Methods"},{"key":"10.1016\/bs.irn.2015.05.002_bb0785","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nbt0196-61","article-title":"From proteins to proteomes: Large scale protein identification by two-dimensional electrophoresis and amino acid analysis","volume":"14","author":"Wilkins","year":"1996","journal-title":"Biotechnology (NY)"},{"key":"10.1016\/bs.irn.2015.05.002_bb0790","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1568008043339785","article-title":"Targeting the ERK pathway: Novel therapeutics for thyroid cancer","volume":"4","author":"Williams","year":"2004","journal-title":"Current Drug Targets. Immune, Endocrine and Metabolic Disorders"},{"key":"10.1016\/bs.irn.2015.05.002_bb0795","first-page":"242","article-title":"Shotgun proteomics: Tools for the analysis of complex biological systems","volume":"4","author":"Wu","year":"2002","journal-title":"Current Opinion in Molecular Therapeutics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0800","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.2741\/2973","article-title":"Proteomic identification of novel proteins associated with Lewy bodies","volume":"13","author":"Xia","year":"2008","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/bs.irn.2015.05.002_bb0805","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1074\/mcp.M700467-MCP200","article-title":"Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease","volume":"7","author":"Xun","year":"2008","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0810","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-130476","article-title":"Shotgun brain proteomics reveals early molecular signature in presymptomatic mouse model of Alzheimer's disease","volume":"37","author":"Yang","year":"2013","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/bs.irn.2015.05.002_bb0815","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-bioeng-061008-124934","article-title":"Proteomics by mass spectrometry: Approaches, advances, and applications","volume":"11","author":"Yates","year":"2009","journal-title":"Annual Review of Biomedical Engineering"},{"key":"10.1016\/bs.irn.2015.05.002_bb0820","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrm2780","article-title":"Building ubiquitin chains: E2 enzymes at work","volume":"10","author":"Ye","year":"2009","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0825","first-page":"96","article-title":"Tissue sample preparation\u2014Not the same old grind","volume":"17","author":"Yu","year":"2004","journal-title":"LC-GC Europe"},{"key":"10.1016\/bs.irn.2015.05.002_bb0830","first-page":"3752","article-title":"Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size","volume":"55","author":"Yuan","year":"1995","journal-title":"Cancer Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0835","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0074-7742(04)61010-5","article-title":"Influence of Huntington's disease on the human and mouse proteome","volume":"61","author":"Zabel","year":"2004","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/bs.irn.2015.05.002_bb0840","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1074\/mcp.M800277-MCP200","article-title":"A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease","volume":"8","author":"Zabel","year":"2009","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0845","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1471-4159.2012.07737.x","article-title":"Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients","volume":"121","author":"Zahid","year":"2012","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2015.05.002_bb0850","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1074\/mcp.M113.036079","article-title":"Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology","volume":"13","author":"Zareba-Koziol","year":"2014","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/bs.irn.2015.05.002_bb0855","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1021\/pr901024z","article-title":"Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model","volume":"9","author":"Zhang","year":"2010","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0860","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2010.05.063","article-title":"Proteome analysis of the sera from Chinese Parkinson's disease patients","volume":"479","author":"Zhao","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.1016\/bs.irn.2015.05.002_bb0865","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1021\/pr100409r","article-title":"Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: Discovery by a proteomics approach","volume":"9","author":"Zhou","year":"2010","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.irn.2015.05.002_bb0870","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/jxb\/erj168","article-title":"A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies","volume":"57","author":"Zieske","year":"2006","journal-title":"Journal of Experimental Botany"},{"key":"10.1016\/bs.irn.2015.05.002_bb0875","first-page":"366","article-title":"The hunt for dying neurons: Insight into the neuronal loss in Alzheimer's disease","volume":"107","author":"Zilkova","year":"2006","journal-title":"Bratislavsk\u00e9 Lek\u00e1rske Listy"}],"container-title":["International Review of Neurobiology","Omic Studies of Neurodegenerative Disease: Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774215000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774215000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T10:42:14Z","timestamp":1566902534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774215000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9780128014806"],"references-count":175,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2015.05.002","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}